Article 14 Jul 2022 It's A Heartache: FDA's OPDP Issues An Untitled Letter For Unlawful Promotion Of A Cholesterol-Lowering Drug Product United States Healthcare
Article 19 Apr 2022 Out Of Touch: FDA Takes Exception With Drug Company's Promotion For Topical Drug Product United States Healthcare
Article 31 Mar 2022 Roll With The Changes: FDA's Proposed Amendments To Converge Its Quality Management System Requirements With ISO Requirements United States Healthcare
Article 04 Mar 2022 Slow Down, You Move Too Fast: OPDP Issues A Warning Letter For Promoting An Investigational New Drug United States Healthcare
Article 23 Feb 2022 You Cannot Do It Any Way You Want It: FDA Issues An Untitled Letter For An Incomplete Journey Forward United States Healthcare